White label ELPA - ClinicalTrials.eu

Study of Fitusiran for Preventing Bleeding in Boys Aged 1 to 12 with Hemophilia A or B

Not recruiting

4 1 1
Investigated Drugs:
- Fitusiran
Study on Noradrenaline and Terlipressin for Treating Septic Shock in Patients

Not recruiting

3 1 1
Investigated Diseases:
- Septic shock
- Sepsis
Investigated Drugs:
- Terlipressin Acetate
- Noradrenaline Tartrate
Study of Olezarsen (ISIS 678354) in Patients with Severe Hypertriglyceridemia: Testing Effects on Triglyceride Levels

Not recruiting

3 1
Investigated Diseases:
- Familial hypertriglyceridaemia
- Hyperchylomicronaemia
Investigated Drugs:
- Isis 678354 Sodium Salt
+9
Study on the Safety and Immune Response of RSVPreF3 Vaccine for Respiratory Syncytial Virus in Adults Aged 60 and Above

Not recruiting

3 1 1 1
Investigated Drugs:
- Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
Study on the Effects of Acalabrutinib in Patients with Relapsed or Refractory Mantle Cell Lymphoma

Not recruiting

2 1 1 1
Investigated Drugs:
- Acalabrutinib
Study of Datopotamab Deruxtecan, Durvalumab, and Carboplatin for Advanced Non-Small Cell Lung Cancer in Patients Without Actionable Genomic Alterations

Not recruiting

3 1 1 1
Investigated Drugs:
+4
Study on Adding Capecitabine to Carboplatin-Based Chemotherapy for Patients with Early Triple Negative Breast Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Breast cancer
Investigated Drugs:
Study Comparing Chemotherapy Alone to Chemotherapy with Nivolumab or Nivolumab and BMS-986205 for Patients with Muscle-Invasive Bladder Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
- Bladder cancer
Investigated Drugs:
+5
Study of Durvalumab with Gemcitabine and Cisplatin for Patients with Advanced Biliary Tract Cancer

Not recruiting

3 1 1 1
Investigated Drugs:
Study on Guselkumab for Patients with Moderate-to-Severe Plaque Psoriasis

Not recruiting

3 1
Investigated Diseases:
- Psoriasis
Investigated Drugs:
- Guselkumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies